(Q34399520)

1 August 2017

title

Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study (English)

1 reference

1 August 2017

0 references

1 reference

irritable bowel syndrome

1 reference

1 reference

9

Alan R Zinsmeister

1 reference

1 August 2017

2

Michael Camilleri

1 reference

1 August 2017

3

Sanna McKinzie

1 reference

1 August 2017

6

Duane Burton

1 reference

1 August 2017

1

Filippo Cremonini

1 reference

1 August 2017

Christopher E Camilleri

series ordinal

5

object named as

Christopher E Camilleri

1 reference

1 August 2017

7

George Thomforde

1 reference

1 August 2017

8

Raul Urrutia

1 reference

1 August 2017

Paula Carlson

4

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

The American Journal of Gastroenterology

1 August 2017

published in

1 reference

1 August 2017

volume

100

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

652-663

1 reference

The irritable bowel syndrome: mechanisms and a practical approach to management

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

AGA technical review on irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Pharmacogenetics in the laboratory and the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

No association of CCK and CCK(B) receptor polymorphisms with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

Effect of cholecystokinin octapeptide and atropine on human colonic motility, tone, and transit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41081.X

10.1111/J.1572-0241.2005.41081.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference